Skip to main content
Top
Published in: Rheumatology International 10/2007

01-08-2007 | Original Article

Prostaglandin E2 receptors EP1 and EP4 are up-regulated in rabbit chondrocytes by IL-1β, but not by TNFα

Authors: M. Angeles Alvarez-Soria, Raquel Largo, Olga Sanchez-Pernaute, Emilio Calvo, Jesús Egido, Gabriel Herrero-Beaumont

Published in: Rheumatology International | Issue 10/2007

Login to get access

Abstract

Prostaglandin E2 (PGE2) exerts its actions through the binding of the high affinity EP receptors. We wanted to evaluate the regulation of EP1 and EP4, and the expression of cyclooxigenase (COX)-2, main enzyme responsible for PGE2 synthesis in inflammatory situations, in healthy rabbit chondrocytes stimulated with inflammatory mediators locally increased during osteoarthritis. Articular chondrocytes obtained from healthy rabbits were stimulated with interleukin (IL)-1β (0.1–100 u/ml) or tumour necrosis factor (TNF)α (100 ng/ml). Where indicated, cells were preincubated with non-steroidal antiinflammatory drugs (NSAIDs) (10−6 M) to inhibit PGE2 synthesis. IL-1β induced a dose and time-dependent increase in EP1, EP4 and COX-2 expression. However, TNFα presence did not induce a significant modification in EP1, EP4 or COX-2 gene expression at any time of study. NSAID presence significantly inhibited PGE2 release but did not modify the EP receptors or COX-2 expression induced by IL-1β. Our results indicate that EP1 and EP4 receptors, and COX-2 are up-regulated in IL-1β-stimulated chondrocytes, while no significant modifications are observed in TNFα-stimulated cells. NSAIDs were unable to modify the expression of these mediators induced by IL-1β. Therefore, the increase in PGE2 synthesis, induced by IL-1β, does not seem to mediate the increase in EP receptor expression, in rabbit chondrocytes.
Literature
1.
go back to reference Abramson SB, Attur M, Amin AR, Clancy R (2001) Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3:535–541PubMedCrossRef Abramson SB, Attur M, Amin AR, Clancy R (2001) Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3:535–541PubMedCrossRef
2.
go back to reference Calvo E, Palacios I, Delgado E, Sánchez O, Hernández P, Ruiz-Cabello J, Moreno J, Egido J, Herrero-Beaumont G (2001) High resolution MRI shows that increased cartilage thickness precedes subchondral remodeling in experimental osteoarthritis. Osteoarthritis Cartilage 9:463–472PubMedCrossRef Calvo E, Palacios I, Delgado E, Sánchez O, Hernández P, Ruiz-Cabello J, Moreno J, Egido J, Herrero-Beaumont G (2001) High resolution MRI shows that increased cartilage thickness precedes subchondral remodeling in experimental osteoarthritis. Osteoarthritis Cartilage 9:463–472PubMedCrossRef
3.
go back to reference Barakat AF, Elson CJ, Westacott CI (2002) Susceptibility to physiological concentrations of IL-1beta varies in cartilage at different anatomical locations on human osteoarthritic knee joints. Osteoarthritis Cartilage 10:264–269PubMedCrossRef Barakat AF, Elson CJ, Westacott CI (2002) Susceptibility to physiological concentrations of IL-1beta varies in cartilage at different anatomical locations on human osteoarthritic knee joints. Osteoarthritis Cartilage 10:264–269PubMedCrossRef
4.
go back to reference Martel-Pelletier J, Pelletier JP, Fahmi H (2003) Cyclooxygenase-2 and prostaglandins in articular tissues. Sem Arthritis Rheum 33:155–167CrossRef Martel-Pelletier J, Pelletier JP, Fahmi H (2003) Cyclooxygenase-2 and prostaglandins in articular tissues. Sem Arthritis Rheum 33:155–167CrossRef
5.
go back to reference Amin AR, Attur MG, Abramson SB (1999) Regulation of nitric oxide and inflammatory mediators in human osteoarthritis-affected cartilage: implication for pharmacological intervention. In: Rubanyi GM (ed) The pathophysiology and clinical applications of nitric oxide. Harwood Academic Newark, pp 397–413 Amin AR, Attur MG, Abramson SB (1999) Regulation of nitric oxide and inflammatory mediators in human osteoarthritis-affected cartilage: implication for pharmacological intervention. In: Rubanyi GM (ed) The pathophysiology and clinical applications of nitric oxide. Harwood Academic Newark, pp 397–413
6.
go back to reference Lotz M (2001) Cytokines in cartilage injury and repair. Clin Orthop Suppl 391:S108–S115CrossRef Lotz M (2001) Cytokines in cartilage injury and repair. Clin Orthop Suppl 391:S108–S115CrossRef
7.
go back to reference Vincenti MP, Brinckerhoff CE (2001) Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1 beta. Arthritis Res Ther 3:381–388 Vincenti MP, Brinckerhoff CE (2001) Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1 beta. Arthritis Res Ther 3:381–388
8.
go back to reference Berenbaum F, Jacques C, Thomas G, Corvol MT, Bereziat G, Masliah J (1996) Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation. Exp Cell Res 222:379–384PubMedCrossRef Berenbaum F, Jacques C, Thomas G, Corvol MT, Bereziat G, Masliah J (1996) Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation. Exp Cell Res 222:379–384PubMedCrossRef
9.
go back to reference Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, Stuchin SA, Patel IR, Abramson SB (1997) Superinduction of COX-2 activity in human osteoarthritic affected cartilage: Influence of nitric oxide. J Clin Invest 99:1231–1237PubMed Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, Stuchin SA, Patel IR, Abramson SB (1997) Superinduction of COX-2 activity in human osteoarthritic affected cartilage: Influence of nitric oxide. J Clin Invest 99:1231–1237PubMed
10.
go back to reference Goetzl EJ, An S, Smith WL (1995) Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J 9:1051–1058PubMed Goetzl EJ, An S, Smith WL (1995) Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J 9:1051–1058PubMed
11.
go back to reference Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661–690PubMedCrossRef Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661–690PubMedCrossRef
12.
go back to reference Largo R, Díez-Ortego I, Sanchez-Pernaute O, Lopez-Armada MJ, Alvarez-Soria MA, Egido J, Herrero-Beaumont G. (2004) EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts. Ann Rheum Dis 63:1197–1204PubMedCrossRef Largo R, Díez-Ortego I, Sanchez-Pernaute O, Lopez-Armada MJ, Alvarez-Soria MA, Egido J, Herrero-Beaumont G. (2004) EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts. Ann Rheum Dis 63:1197–1204PubMedCrossRef
13.
go back to reference Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193–1226PubMed Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193–1226PubMed
14.
go back to reference Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M (2004) Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J Leukoc Biol 76:227–236PubMedCrossRef Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M (2004) Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J Leukoc Biol 76:227–236PubMedCrossRef
15.
go back to reference Largo R, Alvarez-Soria MA, Díez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J, Herrero-Beaumont G (2003). Glucosamine inhibits IL-1beta-induced NFkB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11:290–298PubMedCrossRef Largo R, Alvarez-Soria MA, Díez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J, Herrero-Beaumont G (2003). Glucosamine inhibits IL-1beta-induced NFkB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11:290–298PubMedCrossRef
16.
go back to reference Reginato AM, Lozzo RV, Jimenez SA (1994). Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate. Arthritis Rheum 37:1338–1349PubMedCrossRef Reginato AM, Lozzo RV, Jimenez SA (1994). Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate. Arthritis Rheum 37:1338–1349PubMedCrossRef
17.
go back to reference Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocynate-phenolchloroform extraction. Anal Biochem 162:152–159CrossRef Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocynate-phenolchloroform extraction. Anal Biochem 162:152–159CrossRef
18.
go back to reference Guan Y, Chan M, Cho W, Zhang Y, Redha R, Davis L, Chang S, DuBois RN, Hao CM, Breyer M (1997) Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. Am J Physiol 273:F18–F16PubMed Guan Y, Chan M, Cho W, Zhang Y, Redha R, Davis L, Chang S, DuBois RN, Hao CM, Breyer M (1997) Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. Am J Physiol 273:F18–F16PubMed
19.
go back to reference Guan Y, Zhang Y, Breyer RM, Fowler B, Davis L, Hebert RL, Breyer MD (1998) Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor. J Clin Invest 102:194–201PubMedCrossRef Guan Y, Zhang Y, Breyer RM, Fowler B, Davis L, Hebert RL, Breyer MD (1998) Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor. J Clin Invest 102:194–201PubMedCrossRef
20.
go back to reference Breyer RM DL, Nian C, Redha R, Stillman B, Jacobson HR, Breyer MD (1996) Cloning and expression of the rabbit prostaglandin EP4 receptor. Am J Physiol 270:F485–F493PubMed Breyer RM DL, Nian C, Redha R, Stillman B, Jacobson HR, Breyer MD (1996) Cloning and expression of the rabbit prostaglandin EP4 receptor. Am J Physiol 270:F485–F493PubMed
21.
go back to reference Bertolini A, Ottani A, Sandrini M (2001) Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res 44:437–450PubMedCrossRef Bertolini A, Ottani A, Sandrini M (2001) Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res 44:437–450PubMedCrossRef
22.
go back to reference Fulkerson JP, Damiano P (1983) Effect of prostaglandin E2 on adult pig articular cartilage slices in culture. Clin Orthop Relat Res 179:266–269PubMed Fulkerson JP, Damiano P (1983) Effect of prostaglandin E2 on adult pig articular cartilage slices in culture. Clin Orthop Relat Res 179:266–269PubMed
23.
go back to reference Noguchi K, Shitashige M, Endo H, Kondo H, Ishikawa I (2002) Binary regulation of interleukin-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1 -stimulated human gingival fibroblasts. J Periodontal Res 37:29–36PubMedCrossRef Noguchi K, Shitashige M, Endo H, Kondo H, Ishikawa I (2002) Binary regulation of interleukin-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1 -stimulated human gingival fibroblasts. J Periodontal Res 37:29–36PubMedCrossRef
24.
go back to reference Yamane H, Sugimoto Y, Tanaka S, Ichikawa A (2000) Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem Biophys Res Commun 278:224–228PubMedCrossRef Yamane H, Sugimoto Y, Tanaka S, Ichikawa A (2000) Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem Biophys Res Commun 278:224–228PubMedCrossRef
25.
go back to reference Fehrenbacher JC, Burkey TH, Nicol GD, Vasko MR (2005) Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E(2) receptor mRNA levels in cultured dorsal root ganglia cells. Pain 113:113–122PubMedCrossRef Fehrenbacher JC, Burkey TH, Nicol GD, Vasko MR (2005) Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E(2) receptor mRNA levels in cultured dorsal root ganglia cells. Pain 113:113–122PubMedCrossRef
26.
go back to reference Spaziani EP, Benoit RR, Tsibris JC, Gould SF, O’Brien WF (1998) Tumor necrosis factor-alpha upregulates the prostaglandin E2 EP1 receptor subtype and the cyclooxygenase-2 isoform in cultured amnion WISH cells. J Interferon Cytokine Res 18:1039–1044PubMedCrossRef Spaziani EP, Benoit RR, Tsibris JC, Gould SF, O’Brien WF (1998) Tumor necrosis factor-alpha upregulates the prostaglandin E2 EP1 receptor subtype and the cyclooxygenase-2 isoform in cultured amnion WISH cells. J Interferon Cytokine Res 18:1039–1044PubMedCrossRef
27.
go back to reference De Brum-Fernandes AJ, Morisset S, Bkaily G, Patry C (1996) Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture. Br J Pharmacol 118:1597–1604PubMed De Brum-Fernandes AJ, Morisset S, Bkaily G, Patry C (1996) Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture. Br J Pharmacol 118:1597–1604PubMed
28.
go back to reference Miyamoto M, Ito H, Mukai S, Kobayashi T, Yamamoto H, Kobayashi M, Maruyama T, Akiyama H, Nakamura T (2003) Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthritis Cartilage 11:644–652PubMedCrossRef Miyamoto M, Ito H, Mukai S, Kobayashi T, Yamamoto H, Kobayashi M, Maruyama T, Akiyama H, Nakamura T (2003) Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthritis Cartilage 11:644–652PubMedCrossRef
29.
go back to reference Malfait AM, Verbruggen G, Veys EM, Lambert J, De Ridder L, Cornelissen M (1994) Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheumatol 21:314–320PubMed Malfait AM, Verbruggen G, Veys EM, Lambert J, De Ridder L, Cornelissen M (1994) Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheumatol 21:314–320PubMed
30.
go back to reference Sylvia VL, Del Toro F Jr, Hardin RR, Dean DD, Boyan BD, Schwartz Z (2001) Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes. J Steroid Biochem Mol Biol 78:261–274PubMedCrossRef Sylvia VL, Del Toro F Jr, Hardin RR, Dean DD, Boyan BD, Schwartz Z (2001) Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes. J Steroid Biochem Mol Biol 78:261–274PubMedCrossRef
31.
go back to reference Fushimi K, Nakashima S, Banno Y, Akaike A, Takigawa M, Shimizu K (2004) Implication of prostaglandin E(2) in TNF-alpha-induced release of m-calpain from HCS-2/8 chondrocytes. Inhibition of m-calpain release by NSAIDs. Osteoarthritis Cartilage 12:895–903PubMedCrossRef Fushimi K, Nakashima S, Banno Y, Akaike A, Takigawa M, Shimizu K (2004) Implication of prostaglandin E(2) in TNF-alpha-induced release of m-calpain from HCS-2/8 chondrocytes. Inhibition of m-calpain release by NSAIDs. Osteoarthritis Cartilage 12:895–903PubMedCrossRef
32.
go back to reference Gomez-Barrena E, Sánchez-Pernaute O, Largo R, Calvo E, Esbrit P, Herrero-Beaumont G (2004) Sequential changes of parathyroid hormone related protein (PTHrP) in articular cartilage during progression of inflammatory and degenerative arthritis. Ann Rheum Dis 63:917–922PubMedCrossRef Gomez-Barrena E, Sánchez-Pernaute O, Largo R, Calvo E, Esbrit P, Herrero-Beaumont G (2004) Sequential changes of parathyroid hormone related protein (PTHrP) in articular cartilage during progression of inflammatory and degenerative arthritis. Ann Rheum Dis 63:917–922PubMedCrossRef
33.
go back to reference Klooster AR, Bernier SM (2005) Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Res Ther 7:R127–R138PubMedCrossRef Klooster AR, Bernier SM (2005) Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Res Ther 7:R127–R138PubMedCrossRef
Metadata
Title
Prostaglandin E2 receptors EP1 and EP4 are up-regulated in rabbit chondrocytes by IL-1β, but not by TNFα
Authors
M. Angeles Alvarez-Soria
Raquel Largo
Olga Sanchez-Pernaute
Emilio Calvo
Jesús Egido
Gabriel Herrero-Beaumont
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0328-3

Other articles of this Issue 10/2007

Rheumatology International 10/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.